Decoding the genes behind dolastatin 10 paves the way for new cancer therapeutics

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

University of Florida College of Pharmacy researchers have pinpointed the genetic blueprints behind dolastatin 10, a marine natural product that has led to six FDA-approved cancer drugs since 2011. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
UF Health officials and supporters gathered Wednesday to unveil the UF Health Cancer Center’s Mobile Cancer Screening Connector, which will take cancer screening care to a 23-county area in North Florida. UF Health photo by Nate GuidryThe University of Florida Health Cancer Center launched a 40-foot-long mobile cancer screening bus that will expand access to cancer screenings and essential health care services, including 3D mammograms and cervical, colon, and prostate cancer screenings.
Kate Hitchcock, a UF Health radiation oncologist and an associate professor in the Department of Radiation Oncology in the UF College of Medicine, has been named associate director for access and opportunities at the UF Health Cancer Center. In this role, she will use her experience in leading clinical trials and broad range of healthcare experience to help the center train the next generation of cancer researchers, preparing them to lead advancements in the field.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login